There are 2185 resources available
992O - Pembrolizumab for HPV-associated recurrent respiratory papillomatosis
Presenter: Sara Pai
Session: Proffered paper session: Investigational immunotherapy
Resources:
Abstract
1724MO - The final results of pulmonary resectable metastases of osteosarcoma with antiangiogenic and chemotherapy (PROACH): An open-label, single-arm phase II clinical trial
Presenter: Qiyuan Bao
Session: Mini oral session: Sarcoma
Resources:
Abstract
1148MO - A multivariate efficacy analysis of [177Lu]Lu-DOTA-TATE in the NETTER 2 study
Presenter: Marianne Pavel
Session: Mini oral session: NETs and endocrine tumours
Resources:
Abstract
1725MO - IMMUNOSARC II master trial (phase II of sunitinib and nivolumab): Results from the clear cell sarcoma (CCS) cohort: A GEIS, ISG, and UCL study
Presenter: Javier Martin-Broto
Session: Mini oral session: Sarcoma
Resources:
Abstract
1149MO - Carcinoid heart disease in patients with advanced small-intestinal neuroendocrine tumours and carcinoid syndrome: A retrospective experience of two centers of excellence
Presenter: Laura Algeri
Session: Mini oral session: NETs and endocrine tumours
Resources:
Abstract
1726MO - Updated efficacy and safety of botensilimab plus balstilimab in patients with refractory metastatic sarcoma from an expanded phase I study
Presenter: Breelyn Wilky
Session: Mini oral session: Sarcoma
Resources:
Abstract
1727MO - Can proteomics predict metastatic relapse in leiomyosarcoma (LMS)? Development of an 8 protein signature in a >350 sample study including a validation cohort
Presenter: Elizabeth Connolly
Session: Mini oral session: Sarcoma
Resources:
Abstract
848MO - Phase II open-label randomized study of pembrolizumab with or without bevacizumab in platinum-resistant recurrent/metastatic nasopharyngeal carcinoma (R/M NPC)
Presenter: Wan Qin Chong
Session: Mini oral session: Head and neck cancer
Resources:
Abstract
LBA52 - Interim analysis of GALAXIES Lung-201: Phase II, randomized, open-label platform study of belrestotug plus dostarlimab in patients (pts) with previously untreated locally advanced/metastatic (LA/M) PD-L1 high (TPS >/=50%) non-small cell lung cancer (NSCLC)
Presenter: David R Spigel
Session: Proffered paper session: NSCLC metastatic
Resources:
Abstract
LBA58 - A randomized phase III trial of perioperative chemotherapy (periop CT) with or without preoperative chemoradiotherapy (preop CRT) for resectable gastric cancer (AGITG TOPGEAR): Final results from an intergroup trial of AGITG, TROG, EORTC and CCTG
Presenter: Trevor Leong
Session: Proffered paper session 2: GI tumours, upper digestive
Resources:
Abstract